Low Fiber Can Push Gut Bacteria to Feed on the Gut Lining, Princeton Studies Find

The same raw materials can be steered toward very different products.
Fiber and Prif proteins shift gut bacteria from harmful tyrosine-derived phenols toward healthful phenylalanine-derived ones.
Mark

So what's new here? Everyone says fiber is good for you.

Mimi

The new part is the mechanism. The Princeton teams traced how fiber and certain plant proteins change which phenol chemicals gut bacteria make from the amino acids tyrosine and phenylalanine.

Mark

And the proteins are a surprise?

Mimi

They call them Prifs, proteins imitating fiber. They're indigestible, so they reach the gut bacteria and seem to act a lot like fiber does.

Luke

Careful with the word 'imitating.' What's actually shown is that they shift the phenol balance. The article doesn't say they match fiber in every effect.

Mark

What about the part where bacteria eat the gut lining?

Mimi

That came from experiments in mice. When fiber ran out, bacteria could feed on the mucus lining of the gut and produce potentially harmful compounds.

Luke

Mice, and 'potentially harmful.' Nothing here shows that happens in people eating a low-fiber diet, or how much harm it causes. The human follow-up is listed as future work.

Mark

And the finding about metabolites made outside the gut?

Mimi

Indole-3-lactate and indole-3-acetate were assumed to be purely bacterial. Cells from mice, rats, and humans could make them too.

Luke

Which means a blood level of those chemicals doesn't cleanly tell you what the microbiome did. Still unknown is how much the body's own cells contribute in real life.

Mark

So would Prif labels on food be coming?

Mimi

That's an idea AbuSalim floated, not a plan. It depends on the human work still ahead.

  • Two bacterial pathways start from the same raw amino acids, and only one of them leads to chemicals that protect the body.
  • Fiber and Prif proteins act as a steering force, pushing microbes away from the harmful tyrosine-derived phenols.
  • When fiber disappears in mice, gut bacteria turn on the intestinal mucus lining, producing potentially harmful compounds.
  • Blood metabolites once assumed to come only from gut bacteria are also made by cells elsewhere, complicating how they are read.
  • Researchers are now looking toward human studies to map which dietary parts control which microbial outputs.

Somewhere in the long quiet work of the gut, trillions of microbes are constantly turning what we eat into chemicals that move through our blood and shape our health. Researchers at Princeton, led by Jenna AbuSalim and Joshua Rabinowitz, have begun to show how the plant fiber and indigestible plant proteins they call Prifs act as steering hands on that process, nudging bacteria away from harmful byproducts and toward healthful ones. Their findings, reported in PNAS and Nature Metabolism, give nutrition advice something it has long lacked: an account of the mechanism behind the old promise that plants are good for us.

Two new studies from Princeton University ask a question nutrition advice has mostly taken for granted. We are told plant fiber and protein are good for us, but the how has remained largely hidden. The papers, published in PNAS and Nature Metabolism, follow the health-promoting chemicals, called metabolites, that gut bacteria produce from plant material and that later appear in the blood.

The work was led by molecular biologists Jenna AbuSalim and Joshua Rabinowitz, and it centers on phenol metabolites. Gut bacteria make them while breaking down the amino acids tyrosine and phenylalanine. Phenols from tyrosine are the harmful kind; those from phenylalanine are the healthful kind. The same raw materials can be pushed toward very different outcomes.

The team found that fiber does the steering, along with certain indigestible plant proteins they call 'proteins imitating fiber,' or Prifs. Together they shift bacterial output away from the tyrosine-derived phenols and toward the phenylalanine-derived ones, and the healthful chemicals appear to come mostly from the Prif proteins working alongside fiber. Experiments in mice revealed the other side of the story. When fiber runs short, gut bacteria begin feeding on the mucus lining of the gut, generating compounds that may be harmful. A low-fiber diet, it seems, does more than miss out on benefits.

AbuSalim sees Prifs as an emerging class of nutrients with potentially wide influence on metabolic health, and she imagines a future where food labels list Prif content beside fiber. A second line of the work complicates a common assumption: indole-3-lactate and indole-3-acetate, metabolites linked to health and long thought to come only from gut bacteria, can also be produced by cells outside the gut in mice, rats, and humans. That matters for anyone reading blood levels as a direct window onto the microbiome.

Rabinowitz sees the stakes in therapy. Medicine is increasingly interested in shaping the microbiome or using its products as treatments, and diet offers a powerful lever, but only if researchers know which dietary components control which microbial outputs. The next step is human study: tracking how diet changes affect phenol production over time and examining how tissues beyond the gut make these chemicals. The practical message is familiar but now better grounded, that more plant foods support beneficial gut metabolites, and the hope is that clearer answers will sharpen the advice nutritionists and doctors give.

Two new studies out of Princeton University take on a question that nutrition advice has mostly skipped over: we are told that the fiber and protein in plant foods are good for us, but how, exactly, do they do it? The papers, published in PNAS and Nature Metabolism, trace how plant proteins and fiber lead to health-promoting chemicals, called metabolites, showing up in the blood.

Both were led by molecular biologists Jenna AbuSalim and Joshua Rabinowitz. Their focus was a family of compounds called phenol metabolites, which gut bacteria produce as they break down certain amino acids. Two of those amino acids matter here: tyrosine and phenylalanine. Phenols made from tyrosine are the harmful kind. Those derived from phenylalanine are the healthful kind. The same raw materials, in other words, can be steered toward very different products.

The researchers found that fiber does the steering, and so do certain indigestible plant proteins. They call these proteins 'proteins imitating fiber,' or Prif. According to AbuSalim, both fiber and Prifs shift the balance of phenol metabolites away from the tyrosine-derived variety and toward the phenylalanine-derived one. The healthful chemicals, the work indicates, come almost entirely from the Prif proteins, which work alongside fiber to push bacterial output in the right direction and hold it there.

The flip side emerged in experiments on mice. When fiber runs out, gut bacteria can turn to the mucus lining the walls of the gut as a food source. That produces compounds that are potentially harmful to the body. It is a picture of what a low-fiber diet may do beyond simply missing out on benefits.

AbuSalim describes Prifs as an emerging class of dietary nutrients that shape the makeup of the gut microbiome and could have far-reaching influence on metabolic health. The idea is concrete enough that food packaging might one day list Prif content alongside fiber.

The second line of work complicates a common assumption. Metabolites closely tied to health, long believed to come exclusively from gut bacteria, can also be made elsewhere in the body. Indole-3-lactate and indole-3-acetate are examples: in experiments on cells from mice, rats, and humans, the team found that cells outside the gut could produce them. That matters for anyone trying to read blood levels of these chemicals as a direct signal of what the microbiome is doing.

Rabinowitz frames the stakes in terms of therapy. Interest is growing across medical fields in manipulating the human microbiome, or using its products directly as treatment. Diet, he says, holds great promise for controlling the microbiome and its outputs, but designing effective interventions requires knowing which parts of the diet control which microbial outputs. The studies could inform drugs that act on gut bacteria and help researchers interpret dietary interventions.

The practical takeaway is familiar, if now better supported: more plant foods appear to promote beneficial gut metabolites. What comes next is work on people. The researchers could look at how diet changes affect phenol metabolite production in humans over time, and investigate in more detail how cells outside the gut make the chemicals covered here. Rabinowitz says a clearer picture of how foods interact with the microbiome should sharpen the guidance nutritionists and doctors give for preventing and treating disease.

Both the fiber and indigestible plant proteins shift the balance of phenol metabolites from the harmful kind made from tyrosine to the healthful variety derived from phenylalanine.
— Jenna AbuSalim, Princeton University
To devise effective therapeutic interventions, we need to understand what aspects of the diet control which microbial outputs.
— Joshua Rabinowitz, Princeton University
Envie de l'histoire complète ? Lire l'original sur ScienceAlert ↗
Nous contacter FAQ